FDA Dings Zicam & Matrixx

FDA just issued an advisory about a potential link between certain Zicam products and the loss of sense of small (anosmia).

What's flabbergasting about this is that this information has been around for more than 4 years in the AERS system.

Here you can see that there have been 390 cases of anosmia reported to FDA where Zicam was also mentioned.

Here you can see that, by 2008, adverse event cases for Zicam reported anosmia ~1,000-fold more often than anosmia was reported in all other cases for all other drugs.


This signal is present as far back as Q3 of 2004.